Carlos Garcia-Parada - 13 Sep 2021 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Chief Financial Officer
Signature
/s/ Carlos Garcia-Parada
Issuer symbol
RCKT
Transactions as of
13 Sep 2021
Net transactions value
$0
Form type
4
Filing time
15 Sep 2021, 16:07:33 UTC
Next filing
16 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 13 Sep 2021 Common Stock 40,000 $35.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option represents a right to purchase a total of 40,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on September 13, 2022, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.